Cargando…
The Challenges and the Promise of Molecular Targeted Therapy in Malignant Gliomas()
Malignant gliomas are the most common malignant primary brain tumors and one of the most challenging forms of cancers to treat. Despite advances in conventional treatment, the outcome for patients remains almost universally fatal. This poor prognosis is due to therapeutic resistance and tumor recurr...
Autores principales: | Wang, Hongxiang, Xu, Tao, Jiang, Ying, Xu, Hanchong, Yan, Yong, Fu, Da, Chen, Juxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372648/ https://www.ncbi.nlm.nih.gov/pubmed/25810009 http://dx.doi.org/10.1016/j.neo.2015.02.002 |
Ejemplares similares
-
Gene Fusion in Malignant Glioma: An Emerging Target for Next-Generation Personalized Treatment
por: Xu, Tao, et al.
Publicado: (2018) -
MicroRNA-326 Functions as a Tumor Suppressor in Glioma by Targeting the Nin One Binding Protein (NOB1)
por: Zhou, Jingxu, et al.
Publicado: (2013) -
Microglia and Macrophages in Malignant Gliomas: Recent Discoveries and Implications for Promising Therapies
por: Carvalho da Fonseca, Anna Carolina, et al.
Publicado: (2013) -
Oncogene addiction in gliomas: Implications for molecular targeted therapy
por: Yan, Wei, et al.
Publicado: (2011) -
Molecular biomarker‐guided anti‐angiogenic targeted therapy for malignant glioma
por: Yan, Chengrui, et al.
Publicado: (2019)